nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—LIMK2—lymphoid tissue—peritoneum cancer	0.00315	0.00315	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—peritoneum cancer	0.00314	0.00314	CbGeAlD
Crizotinib—IRAK1—decidua—peritoneum cancer	0.00314	0.00314	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—peritoneum cancer	0.00311	0.00311	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—peritoneum cancer	0.00311	0.00311	CbGeAlD
Crizotinib—TNK2—female gonad—peritoneum cancer	0.00309	0.00309	CbGeAlD
Crizotinib—IGF1R—female gonad—peritoneum cancer	0.00309	0.00309	CbGeAlD
Crizotinib—EPHB4—epithelium—peritoneum cancer	0.00308	0.00308	CbGeAlD
Crizotinib—RPS6KB1—decidua—peritoneum cancer	0.00308	0.00308	CbGeAlD
Crizotinib—JAK2—epithelium—peritoneum cancer	0.00306	0.00306	CbGeAlD
Crizotinib—LCK—decidua—peritoneum cancer	0.00306	0.00306	CbGeAlD
Crizotinib—FGR—decidua—peritoneum cancer	0.00306	0.00306	CbGeAlD
Crizotinib—AXL—decidua—peritoneum cancer	0.00305	0.00305	CbGeAlD
Crizotinib—ACVR1B—liver—peritoneum cancer	0.00304	0.00304	CbGeAlD
Crizotinib—MAP4K2—female gonad—peritoneum cancer	0.00304	0.00304	CbGeAlD
Crizotinib—TBK1—endometrium—peritoneum cancer	0.00304	0.00304	CbGeAlD
Crizotinib—PRKD1—lymph node—peritoneum cancer	0.00304	0.00304	CbGeAlD
Crizotinib—EPHA2—epithelium—peritoneum cancer	0.00303	0.00303	CbGeAlD
Crizotinib—TYK2—endometrium—peritoneum cancer	0.00302	0.00302	CbGeAlD
Crizotinib—STK3—female gonad—peritoneum cancer	0.003	0.003	CbGeAlD
Crizotinib—TIE1—female gonad—peritoneum cancer	0.003	0.003	CbGeAlD
Crizotinib—LIMK1—lymph node—peritoneum cancer	0.003	0.003	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—peritoneum cancer	0.00297	0.00297	CbGeAlD
Crizotinib—TEK—epithelium—peritoneum cancer	0.00295	0.00295	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—peritoneum cancer	0.00295	0.00295	CbGeAlD
Crizotinib—SLK—decidua—peritoneum cancer	0.00293	0.00293	CbGeAlD
Crizotinib—AURKA—female gonad—peritoneum cancer	0.00293	0.00293	CbGeAlD
Crizotinib—RPS6KB1—endometrium—peritoneum cancer	0.00292	0.00292	CbGeAlD
Crizotinib—PRKD3—lymph node—peritoneum cancer	0.00292	0.00292	CbGeAlD
Crizotinib—EPHA4—uterus—peritoneum cancer	0.00292	0.00292	CbGeAlD
Crizotinib—EPHB4—decidua—peritoneum cancer	0.00291	0.00291	CbGeAlD
Crizotinib—FGR—endometrium—peritoneum cancer	0.00291	0.00291	CbGeAlD
Crizotinib—TESK1—female gonad—peritoneum cancer	0.0029	0.0029	CbGeAlD
Crizotinib—AXL—endometrium—peritoneum cancer	0.00289	0.00289	CbGeAlD
Crizotinib—JAK2—decidua—peritoneum cancer	0.00289	0.00289	CbGeAlD
Crizotinib—MAP3K2—uterus—peritoneum cancer	0.00286	0.00286	CbGeAlD
Crizotinib—EPHA2—decidua—peritoneum cancer	0.00286	0.00286	CbGeAlD
Crizotinib—STK4—liver—peritoneum cancer	0.00285	0.00285	CbGeAlD
Crizotinib—DSTYK—lymph node—peritoneum cancer	0.00285	0.00285	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—peritoneum cancer	0.00284	0.00284	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—peritoneum cancer	0.00284	0.00284	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—peritoneum cancer	0.00284	0.00284	CbGeAlD
Crizotinib—MERTK—female gonad—peritoneum cancer	0.00282	0.00282	CbGeAlD
Crizotinib—BLK—lymph node—peritoneum cancer	0.00282	0.00282	CbGeAlD
Crizotinib—PTK2—uterus—peritoneum cancer	0.0028	0.0028	CbGeAlD
Crizotinib—MAP3K3—decidua—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—TEK—decidua—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—MAP4K5—decidua—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—SLK—endometrium—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—LTK—lymph node—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—CASK—lymph node—peritoneum cancer	0.00279	0.00279	CbGeAlD
Crizotinib—TYK2—uterus—peritoneum cancer	0.00278	0.00278	CbGeAlD
Crizotinib—EPHB4—endometrium—peritoneum cancer	0.00277	0.00277	CbGeAlD
Crizotinib—LIMK2—female gonad—peritoneum cancer	0.00276	0.00276	CbGeAlD
Crizotinib—NUAK2—female gonad—peritoneum cancer	0.00275	0.00275	CbGeAlD
Crizotinib—JAK2—endometrium—peritoneum cancer	0.00275	0.00275	CbGeAlD
Crizotinib—MAP3K12—female gonad—peritoneum cancer	0.00273	0.00273	CbGeAlD
Crizotinib—FLT3—female gonad—peritoneum cancer	0.00273	0.00273	CbGeAlD
Crizotinib—ACVR1—female gonad—peritoneum cancer	0.00273	0.00273	CbGeAlD
Crizotinib—EPHA2—endometrium—peritoneum cancer	0.00271	0.00271	CbGeAlD
Crizotinib—MAPK7—lymph node—peritoneum cancer	0.0027	0.0027	CbGeAlD
Crizotinib—TXK—lymph node—peritoneum cancer	0.0027	0.0027	CbGeAlD
Crizotinib—FER—liver—peritoneum cancer	0.00269	0.00269	CbGeAlD
Crizotinib—LYN—liver—peritoneum cancer	0.00268	0.00268	CbGeAlD
Crizotinib—LCK—uterus—peritoneum cancer	0.00268	0.00268	CbGeAlD
Crizotinib—STK35—female gonad—peritoneum cancer	0.00268	0.00268	CbGeAlD
Crizotinib—FES—lymph node—peritoneum cancer	0.00267	0.00267	CbGeAlD
Crizotinib—AXL—uterus—peritoneum cancer	0.00267	0.00267	CbGeAlD
Crizotinib—TNK1—liver—peritoneum cancer	0.00267	0.00267	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—peritoneum cancer	0.00267	0.00267	CbGeAlD
Crizotinib—EPHB6—decidua—peritoneum cancer	0.00267	0.00267	CbGeAlD
Crizotinib—TEK—endometrium—peritoneum cancer	0.00265	0.00265	CbGeAlD
Crizotinib—MAP3K3—endometrium—peritoneum cancer	0.00265	0.00265	CbGeAlD
Crizotinib—MAP4K5—endometrium—peritoneum cancer	0.00265	0.00265	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—peritoneum cancer	0.00263	0.00263	CbGeAlD
Crizotinib—SRC—epithelium—peritoneum cancer	0.00262	0.00262	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—peritoneum cancer	0.00261	0.00261	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—peritoneum cancer	0.00261	0.00261	CbGeAlD
Crizotinib—ABL2—female gonad—peritoneum cancer	0.00261	0.00261	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—peritoneum cancer	0.00259	0.00259	CbGeAlD
Crizotinib—TNK2—liver—peritoneum cancer	0.00259	0.00259	CbGeAlD
Crizotinib—IGF1R—liver—peritoneum cancer	0.00259	0.00259	CbGeAlD
Crizotinib—BMP2K—female gonad—peritoneum cancer	0.00258	0.00258	CbGeAlD
Crizotinib—YES1—decidua—peritoneum cancer	0.00258	0.00258	CbGeAlD
Crizotinib—SLK—uterus—peritoneum cancer	0.00257	0.00257	CbGeAlD
Crizotinib—MAP4K2—liver—peritoneum cancer	0.00255	0.00255	CbGeAlD
Crizotinib—STK10—decidua—peritoneum cancer	0.00255	0.00255	CbGeAlD
Crizotinib—EPHB4—uterus—peritoneum cancer	0.00255	0.00255	CbGeAlD
Crizotinib—TAOK3—decidua—peritoneum cancer	0.00254	0.00254	CbGeAlD
Crizotinib—EPHB6—endometrium—peritoneum cancer	0.00253	0.00253	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—peritoneum cancer	0.00253	0.00253	CbGeAlD
Crizotinib—MET—lymph node—peritoneum cancer	0.00252	0.00252	CbGeAlD
Crizotinib—TIE1—liver—peritoneum cancer	0.00252	0.00252	CbGeAlD
Crizotinib—STK3—liver—peritoneum cancer	0.00252	0.00252	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—peritoneum cancer	0.00251	0.00251	CbGeAlD
Crizotinib—FGR—lymphoid tissue—peritoneum cancer	0.0025	0.0025	CbGeAlD
Crizotinib—PTK2B—female gonad—peritoneum cancer	0.00249	0.00249	CbGeAlD
Crizotinib—AXL—lymphoid tissue—peritoneum cancer	0.00249	0.00249	CbGeAlD
Crizotinib—SRC—decidua—peritoneum cancer	0.00248	0.00248	CbGeAlD
Crizotinib—RIPK2—female gonad—peritoneum cancer	0.00247	0.00247	CbGeAlD
Crizotinib—AURKA—liver—peritoneum cancer	0.00245	0.00245	CbGeAlD
Crizotinib—YES1—endometrium—peritoneum cancer	0.00244	0.00244	CbGeAlD
Crizotinib—CDK7—lymph node—peritoneum cancer	0.00244	0.00244	CbGeAlD
Crizotinib—MAP4K5—uterus—peritoneum cancer	0.00244	0.00244	CbGeAlD
Crizotinib—TEK—uterus—peritoneum cancer	0.00244	0.00244	CbGeAlD
Crizotinib—TESK1—liver—peritoneum cancer	0.00243	0.00243	CbGeAlD
Crizotinib—TAOK2—lymph node—peritoneum cancer	0.00242	0.00242	CbGeAlD
Crizotinib—TAOK3—endometrium—peritoneum cancer	0.00241	0.00241	CbGeAlD
Crizotinib—EPHA4—female gonad—peritoneum cancer	0.00239	0.00239	CbGeAlD
Crizotinib—MERTK—liver—peritoneum cancer	0.00237	0.00237	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—peritoneum cancer	0.00236	0.00236	CbGeAlD
Crizotinib—MAP3K2—female gonad—peritoneum cancer	0.00234	0.00234	CbGeAlD
Crizotinib—ACVR1B—lymph node—peritoneum cancer	0.00233	0.00233	CbGeAlD
Crizotinib—EPHA3—lymph node—peritoneum cancer	0.00233	0.00233	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—peritoneum cancer	0.00233	0.00233	CbGeAlD
Crizotinib—LIMK2—liver—peritoneum cancer	0.00232	0.00232	CbGeAlD
Crizotinib—NUAK2—liver—peritoneum cancer	0.00231	0.00231	CbGeAlD
Crizotinib—PTK2—female gonad—peritoneum cancer	0.00229	0.00229	CbGeAlD
Crizotinib—TBK1—female gonad—peritoneum cancer	0.00229	0.00229	CbGeAlD
Crizotinib—MAP3K12—liver—peritoneum cancer	0.00229	0.00229	CbGeAlD
Crizotinib—FLT3—liver—peritoneum cancer	0.00229	0.00229	CbGeAlD
Crizotinib—ACVR1—liver—peritoneum cancer	0.00229	0.00229	CbGeAlD
Crizotinib—TYK2—female gonad—peritoneum cancer	0.00228	0.00228	CbGeAlD
Crizotinib—TEK—lymphoid tissue—peritoneum cancer	0.00227	0.00227	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—peritoneum cancer	0.00227	0.00227	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—peritoneum cancer	0.00227	0.00227	CbGeAlD
Crizotinib—YES1—uterus—peritoneum cancer	0.00225	0.00225	CbGeAlD
Crizotinib—IRAK1—female gonad—peritoneum cancer	0.00225	0.00225	CbGeAlD
Crizotinib—STK35—liver—peritoneum cancer	0.00224	0.00224	CbGeAlD
Crizotinib—STK10—uterus—peritoneum cancer	0.00223	0.00223	CbGeAlD
Crizotinib—JAK3—lymph node—peritoneum cancer	0.00223	0.00223	CbGeAlD
Crizotinib—CSF1R—decidua—peritoneum cancer	0.00222	0.00222	CbGeAlD
Crizotinib—TAOK3—uterus—peritoneum cancer	0.00222	0.00222	CbGeAlD
Crizotinib—DCLK1—lymph node—peritoneum cancer	0.00221	0.00221	CbGeAlD
Crizotinib—RPS6KB1—female gonad—peritoneum cancer	0.0022	0.0022	CbGeAlD
Crizotinib—PLK4—lymph node—peritoneum cancer	0.0022	0.0022	CbGeAlD
Crizotinib—FGR—female gonad—peritoneum cancer	0.00219	0.00219	CbGeAlD
Crizotinib—LCK—female gonad—peritoneum cancer	0.00219	0.00219	CbGeAlD
Crizotinib—ABL2—liver—peritoneum cancer	0.00219	0.00219	CbGeAlD
Crizotinib—STK4—lymph node—peritoneum cancer	0.00219	0.00219	CbGeAlD
Crizotinib—AXL—female gonad—peritoneum cancer	0.00218	0.00218	CbGeAlD
Crizotinib—BMP2K—liver—peritoneum cancer	0.00216	0.00216	CbGeAlD
Crizotinib—CSF1R—endometrium—peritoneum cancer	0.00211	0.00211	CbGeAlD
Crizotinib—SLK—female gonad—peritoneum cancer	0.0021	0.0021	CbGeAlD
Crizotinib—YES1—lymphoid tissue—peritoneum cancer	0.0021	0.0021	CbGeAlD
Crizotinib—PTK2B—liver—peritoneum cancer	0.00209	0.00209	CbGeAlD
Crizotinib—EPHB4—female gonad—peritoneum cancer	0.00209	0.00209	CbGeAlD
Crizotinib—STK10—lymphoid tissue—peritoneum cancer	0.00208	0.00208	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—peritoneum cancer	0.00207	0.00207	CbGeAlD
Crizotinib—JAK2—female gonad—peritoneum cancer	0.00207	0.00207	CbGeAlD
Crizotinib—RIPK2—liver—peritoneum cancer	0.00207	0.00207	CbGeAlD
Crizotinib—FER—lymph node—peritoneum cancer	0.00207	0.00207	CbGeAlD
Crizotinib—ALK—lymph node—peritoneum cancer	0.00207	0.00207	CbGeAlD
Crizotinib—EPHA2—female gonad—peritoneum cancer	0.00205	0.00205	CbGeAlD
Crizotinib—TNK1—lymph node—peritoneum cancer	0.00204	0.00204	CbGeAlD
Crizotinib—BMPR1B—lymph node—peritoneum cancer	0.00202	0.00202	CbGeAlD
Crizotinib—MAP4K1—lymph node—peritoneum cancer	0.00202	0.00202	CbGeAlD
Crizotinib—SRC—lymphoid tissue—peritoneum cancer	0.00202	0.00202	CbGeAlD
Crizotinib—TEK—female gonad—peritoneum cancer	0.002	0.002	CbGeAlD
Crizotinib—MAP3K3—female gonad—peritoneum cancer	0.002	0.002	CbGeAlD
Crizotinib—MAP4K5—female gonad—peritoneum cancer	0.002	0.002	CbGeAlD
Crizotinib—TNK2—lymph node—peritoneum cancer	0.00198	0.00198	CbGeAlD
Crizotinib—IGF1R—lymph node—peritoneum cancer	0.00198	0.00198	CbGeAlD
Crizotinib—MAP3K2—liver—peritoneum cancer	0.00196	0.00196	CbGeAlD
Crizotinib—MAP4K2—lymph node—peritoneum cancer	0.00196	0.00196	CbGeAlD
Crizotinib—CSF1R—uterus—peritoneum cancer	0.00195	0.00195	CbGeAlD
Crizotinib—TIE1—lymph node—peritoneum cancer	0.00193	0.00193	CbGeAlD
Crizotinib—STK3—lymph node—peritoneum cancer	0.00193	0.00193	CbGeAlD
Crizotinib—PTK2—liver—peritoneum cancer	0.00192	0.00192	CbGeAlD
Crizotinib—TBK1—liver—peritoneum cancer	0.00192	0.00192	CbGeAlD
Crizotinib—TYK2—liver—peritoneum cancer	0.00191	0.00191	CbGeAlD
Crizotinib—EPHB6—female gonad—peritoneum cancer	0.00191	0.00191	CbGeAlD
Crizotinib—IRAK1—liver—peritoneum cancer	0.00188	0.00188	CbGeAlD
Crizotinib—AURKA—lymph node—peritoneum cancer	0.00188	0.00188	CbGeAlD
Crizotinib—TESK1—lymph node—peritoneum cancer	0.00187	0.00187	CbGeAlD
Crizotinib—RPS6KB1—liver—peritoneum cancer	0.00185	0.00185	CbGeAlD
Crizotinib—YES1—female gonad—peritoneum cancer	0.00184	0.00184	CbGeAlD
Crizotinib—LCK—liver—peritoneum cancer	0.00184	0.00184	CbGeAlD
Crizotinib—FGR—liver—peritoneum cancer	0.00184	0.00184	CbGeAlD
Crizotinib—AXL—liver—peritoneum cancer	0.00183	0.00183	CbGeAlD
Crizotinib—STK10—female gonad—peritoneum cancer	0.00183	0.00183	CbGeAlD
Crizotinib—TAOK3—female gonad—peritoneum cancer	0.00182	0.00182	CbGeAlD
Crizotinib—MERTK—lymph node—peritoneum cancer	0.00182	0.00182	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—peritoneum cancer	0.00181	0.00181	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—peritoneum cancer	0.00179	0.00179	CbGeAlD
Crizotinib—LIMK2—lymph node—peritoneum cancer	0.00178	0.00178	CbGeAlD
Crizotinib—SRC—female gonad—peritoneum cancer	0.00177	0.00177	CbGeAlD
Crizotinib—NUAK2—lymph node—peritoneum cancer	0.00177	0.00177	CbGeAlD
Crizotinib—SLK—liver—peritoneum cancer	0.00176	0.00176	CbGeAlD
Crizotinib—ABL1—decidua—peritoneum cancer	0.00176	0.00176	CbGeAlD
Crizotinib—ACVR1—lymph node—peritoneum cancer	0.00176	0.00176	CbGeAlD
Crizotinib—MAP3K12—lymph node—peritoneum cancer	0.00176	0.00176	CbGeAlD
Crizotinib—FLT3—lymph node—peritoneum cancer	0.00176	0.00176	CbGeAlD
Crizotinib—EPHB4—liver—peritoneum cancer	0.00175	0.00175	CbGeAlD
Crizotinib—JAK2—liver—peritoneum cancer	0.00174	0.00174	CbGeAlD
Crizotinib—STK35—lymph node—peritoneum cancer	0.00172	0.00172	CbGeAlD
Crizotinib—EPHA2—liver—peritoneum cancer	0.00172	0.00172	CbGeAlD
Crizotinib—ABL2—lymph node—peritoneum cancer	0.00168	0.00168	CbGeAlD
Crizotinib—MAP4K5—liver—peritoneum cancer	0.00167	0.00167	CbGeAlD
Crizotinib—TEK—liver—peritoneum cancer	0.00167	0.00167	CbGeAlD
Crizotinib—MAP3K3—liver—peritoneum cancer	0.00167	0.00167	CbGeAlD
Crizotinib—ABL1—endometrium—peritoneum cancer	0.00167	0.00167	CbGeAlD
Crizotinib—BMP2K—lymph node—peritoneum cancer	0.00166	0.00166	CbGeAlD
Crizotinib—PTK2B—lymph node—peritoneum cancer	0.0016	0.0016	CbGeAlD
Crizotinib—CSF1R—female gonad—peritoneum cancer	0.00159	0.00159	CbGeAlD
Crizotinib—RIPK2—lymph node—peritoneum cancer	0.00159	0.00159	CbGeAlD
Crizotinib—YES1—liver—peritoneum cancer	0.00155	0.00155	CbGeAlD
Crizotinib—ABL1—uterus—peritoneum cancer	0.00154	0.00154	CbGeAlD
Crizotinib—EPHA4—lymph node—peritoneum cancer	0.00153	0.00153	CbGeAlD
Crizotinib—STK10—liver—peritoneum cancer	0.00153	0.00153	CbGeAlD
Crizotinib—TAOK3—liver—peritoneum cancer	0.00153	0.00153	CbGeAlD
Crizotinib—MAP3K2—lymph node—peritoneum cancer	0.0015	0.0015	CbGeAlD
Crizotinib—SRC—liver—peritoneum cancer	0.00149	0.00149	CbGeAlD
Crizotinib—TBK1—lymph node—peritoneum cancer	0.00147	0.00147	CbGeAlD
Crizotinib—PTK2—lymph node—peritoneum cancer	0.00147	0.00147	CbGeAlD
Crizotinib—TYK2—lymph node—peritoneum cancer	0.00146	0.00146	CbGeAlD
Crizotinib—IRAK1—lymph node—peritoneum cancer	0.00144	0.00144	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—peritoneum cancer	0.00143	0.00143	CbGeAlD
Crizotinib—RPS6KB1—lymph node—peritoneum cancer	0.00142	0.00142	CbGeAlD
Crizotinib—LCK—lymph node—peritoneum cancer	0.00141	0.00141	CbGeAlD
Crizotinib—FGR—lymph node—peritoneum cancer	0.00141	0.00141	CbGeAlD
Crizotinib—AXL—lymph node—peritoneum cancer	0.0014	0.0014	CbGeAlD
Crizotinib—SLK—lymph node—peritoneum cancer	0.00135	0.00135	CbGeAlD
Crizotinib—EPHB4—lymph node—peritoneum cancer	0.00134	0.00134	CbGeAlD
Crizotinib—CSF1R—liver—peritoneum cancer	0.00133	0.00133	CbGeAlD
Crizotinib—JAK2—lymph node—peritoneum cancer	0.00133	0.00133	CbGeAlD
Crizotinib—EPHA2—lymph node—peritoneum cancer	0.00132	0.00132	CbGeAlD
Crizotinib—TEK—lymph node—peritoneum cancer	0.00128	0.00128	CbGeAlD
Crizotinib—MAP4K5—lymph node—peritoneum cancer	0.00128	0.00128	CbGeAlD
Crizotinib—MAP3K3—lymph node—peritoneum cancer	0.00128	0.00128	CbGeAlD
Crizotinib—ABL1—female gonad—peritoneum cancer	0.00126	0.00126	CbGeAlD
Crizotinib—EPHB6—lymph node—peritoneum cancer	0.00123	0.00123	CbGeAlD
Crizotinib—YES1—lymph node—peritoneum cancer	0.00118	0.00118	CbGeAlD
Crizotinib—STK10—lymph node—peritoneum cancer	0.00117	0.00117	CbGeAlD
Crizotinib—TAOK3—lymph node—peritoneum cancer	0.00117	0.00117	CbGeAlD
Crizotinib—SRC—lymph node—peritoneum cancer	0.00114	0.00114	CbGeAlD
Crizotinib—ABL1—liver—peritoneum cancer	0.00105	0.00105	CbGeAlD
Crizotinib—CSF1R—lymph node—peritoneum cancer	0.00102	0.00102	CbGeAlD
Crizotinib—ABL1—lymph node—peritoneum cancer	0.000809	0.000809	CbGeAlD
Crizotinib—CYP3A5—female gonad—peritoneum cancer	0.000736	0.000736	CbGeAlD
Crizotinib—CYP3A5—liver—peritoneum cancer	0.000618	0.000618	CbGeAlD
Crizotinib—ABCB1—epithelium—peritoneum cancer	0.000579	0.000579	CbGeAlD
Crizotinib—ABCB1—decidua—peritoneum cancer	0.000547	0.000547	CbGeAlD
Crizotinib—ABCB1—endometrium—peritoneum cancer	0.000519	0.000519	CbGeAlD
Crizotinib—ABCB1—uterus—peritoneum cancer	0.000478	0.000478	CbGeAlD
Crizotinib—CYP3A4—liver—peritoneum cancer	0.000463	0.000463	CbGeAlD
Crizotinib—ABCB1—lymphoid tissue—peritoneum cancer	0.000446	0.000446	CbGeAlD
Crizotinib—ABCB1—female gonad—peritoneum cancer	0.000391	0.000391	CbGeAlD
Crizotinib—ABCB1—liver—peritoneum cancer	0.000328	0.000328	CbGeAlD
Crizotinib—ABCB1—lymph node—peritoneum cancer	0.000252	0.000252	CbGeAlD
